Pet Diabetes Management Market Set to Reach USD 6.15 Billion by 2035, with an 8.5% CAGR

The global Pet Diabetes Management Market is estimated at USD 2.48 billion in 2024 and is projected to grow at a CAGR of 8.5% during the forecast period 2025-2035. The pet diabetes management market essentially focuses on the diagnosis and treatment of and monitoring diabetes in animals, mainly dogs and cats. Diabetes in animals takes the form of either the inability to produce adequate insulin or the body's inability to use the insulin that is produced. This tends to elevate blood sugar to a level that needs to be controlled over time. The market includes diagnostic tools such as glucose meters, insulin therapy, continuous glucose monitors, and specific diabetic pet foods. Veterinary care services also contribute to changing treatment plans over time. The increase in several pet owners, coupled with an increase in awareness regarding their health and the advancement of veterinary technology, are features that have increased demand for diabetes care products and services in this market.

What are the Top Factors Driving Growth in the Pet Diabetes Management Market?

Increasing obesity in pets is a major contributor to diabetes, leading to higher demand for diabetes management products and services.

Increasing obesity levels among pets is seen to be one of the major drivers for the pet diabetes management market. With obesity having been created as an environment of predisposition to several health issues in pets, one of the health issues is mellitus diabetes, which has gained more prominence in cases of dogs and cats.
Increased awareness of the relationship between obesity and diabetes has led owners to demand specific management products and services meant for the management of pets, like diet plans, glucose monitoring devices, and veterinary consultation services. According to the Association for Pet Obesity Prevention (APOP), around 60 percent of cats and 56 percent of dogs in the United States fall under the category of overweight or obese.

Browse key industry insights spread across 230 pages with 120+ Market data tables and figures & charts from the report on the "Pet Diabetes Management Market By Product Type (Insulin Delivery Devices: {Insulin Pens and Insulin Syringes}, Glucose Monitoring Devices: {Diagnostic kits, Glucometers} Medications:{Oral drugs, Injections, and Others}, By Pet Type (Dogs, Cats, and Others), By Distribution Channel (Online Pharmacies, Pet Specialty Stores, Veterinary Clinics & Hospitals and Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035"

Download an Exclusive Sample of the Report
https://www.metatechinsights.com/request-sample/1108

Emerging technology enables remote monitoring of pets' glucose levels.

The rising rates of obesity in pets have significantly contributed to the growth of the pet diabetes management market. Obesity paves the way for several other health-related issues, among them diabetes mellitus, now increasingly common in dogs and cats.
Pet owners are demanding specialized management goods and services, such as food planning, glucose monitoring devices, and veterinary consultations, as a result of growing awareness of the link between diabetes and obesity. An estimated 60% of cats and 56% of dogs in the United States are classified as overweight or obese, according to the Association for Pet Obesity Prevention (APOP).

What are the significant challenges impacting the Pet Diabetes Management Market?

Regulatory challenges slow down the introduction of new treatment options.

Regulatory challenges are significant barriers to the introduction of new treatments in pet diabetes management. Veterinary medication and device approval are long-winded, complicated, and always subject to considerable testing and documentation of safety and efficacy. This often leads to a delay in the introduction of new innovative solutions to the market, greatly diminishing the choices available for both pet owners and veterinarians. Moreover, over-regulation will push up the cost of development for the therapy; this may scare away smaller firms and young ventures from the market. As a result, fewer new therapies and monitoring tools will be offered to pet owners; this would stall the progress of advancement in diabetes treatment of pets.

What are the attractive investment opportunities that can drive industry growth?

Smart monitoring devices can enhance diabetes management for pet owners.

Smart monitoring devices and new scientific innovations in managing care for pet diabetes help pet owners change the way they manage their pets' health. Advanced tools such as continuous glucose monitors (CGMs) and smartphone apps entail the possibility of tracking glucose with real-time feedback that enables appropriate and timely interventions. The technology thus enhances data accuracy and allows veterinarians to precisely change treatment practices. On top of that, interfaces as well as alert systems that are user-friendly allow pet owners to be more actively engaged in the diabetes management of pets. Increased demand for smart monitoring devices is expected as pet owners increasingly seek to find convenient and effective solutions. Such an upsurge, however, would unlock the opportunity for innovation and marketing of these devices by companies, henceforth leading to healthier pets along with increased revenue through pet diabetes management.

North America Plays a Crucial Role in the Pet Diabetes Management Market Landscape

The North American pet diabetes management market is growing rapidly. The pet ownership rate remains high in the United States and Canada, respectively, leading to more demand for diabetes management solutions. There is growing awareness among pet owners concerning the importance of managing chronic conditions like diabetes, which increases the interest in specialized products as well as veterinary services.
The region also features high-end veterinary healthcare infrastructure providing specialized diabetes management. The region also featured developments in technological smart monitoring devices and telehealth services that further improve diabetes care in pets.

Read more about the report: https://www.metatechinsights.com/industry-insights/pet-diabetes-management-market-1108

Europe, Particularly China and India, Holds a Significant Share of the Pet Diabetes Management Market.

In Europe, the pet diabetes management market is growing rapidly. Higher awareness among pet owners regarding pet health conditions, along with increased pet ownership in European countries, is fuelling the demand for diabetes management services for pets.
European pet owners are now coming forward with their proactive approach towards chronic conditions like diabetes through advanced products and veterinary services. There is a robust veterinary healthcare system present and facilitating the delivery of advanced diabetes care in the region.

Competitive Landscape

The pet diabetes management market is experiencing a highly competitive landscape through several big players. These include Zoetis, Merck Animal Health, Elanco, and Bayer Animal Health, among others. These companies are currently on the frontlines of innovation for diabetes management in pets to further propel market growth. Recently, these include the launch of a new veterinary insulin product designed by Zoetis, whereby this aims to afford better glycemic control over pets. With research and development being the focus, advanced diabetic monitoring devices have been developed as well as systems for insulin delivery to improve diabetes management in pets. With increasing knowledge about pet health, these companies are investing heavily into marketing and education to introduce their various products to pet owners, thus giving them security within this ever-growing market.

Recent Developments

• In May 2023, Petrackr, a diabetes monitoring tool for pets, was introduced by UBI. It comes with a blood sample instrument that uses single-use test strips and a portable monitor that can handle many pet profiles. Petrackr is accessible through distribution partnerships in the United States and Canada and efficiently monitors and shows the blood glucose levels of pets.

Report Coverage:

By Product Type
• Insulin Delivery Devices
o Insulin pens
o Insulin Syringes
• Glucose Monitoring Devices
o Diagnostic kits
o Glucometers
• Medications
o Oral drugs
o Injections
• Others
By Pet Type
• Dogs
• Cats
• Others
By Distribution Channel
• Online Pharmacies
• Pet Specialty Stores
• Veterinary Clinics & Hospitals
• Others
By Region
North America
• U.S.
• Canada
Europe
• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe
Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific
Latin America
• Brazil
• Argentina
• Mexico
• Rest of Latin America
Middle East & Africa
• GCC Countries
• South Africa
• Rest of Middle East & Africa
List of Companies:
• Zoetis
• Merial
• Elanco
• Vetoquinol
• Virbac
• Boehringer Ingelheim
• PetDx
• Diabetes Management Services
• PetSage
• PawTree
• Vet's Best
• Hill's Pet Nutrition
• Royal Canin
• Purina Pro Plan Veterinary Diets
• Chewy, Inc.

Official Email - sales@metatechinsights.com
Website - https://www.metatechinsights.com/
Follow us - LinkedIn I Twitter

Metatech Insights specializes in making comprehensive global and regional market research reports in Healthcare, Chemicals & Materials, Medical Devices, Healthcare IT, and Novel technologies. Our meticulously designed research reports are regarded as one of the most detailed and well-thought market research studies available in the industry. Our reports typically include market assessments, analysis of industry trends and competitive intelligence

This release was published on openPR.